The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Emergency Hospitalizations for Adverse Drug Events in Older Americans
Open accessAbstract
BACKGROUND: Adverse drug events are important preventable causes of hospitalization in older adults. However, nationally representative data on adverse drug events that result in hospitalization in this population have been limited. METHODS: We used adverse-event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2007 through 2009) to estimate the frequency and rates of hospitalization after emergency department visits for adverse drug events in older adults and to assess the contribution of specific medications, including those identified as high-risk or potentially inappropriate by national quality measures. RESULTS: On the basis of 5077 cases identified in our sample, there were an estimated 99,628 emergency hospitalizations (95% confidence interval [CI], 55,531 to 143,724) for adverse drug events in U.S. adults 65 years of age or older each year from 2007 through 2009. Nearly half of these hospitalizations were among adults 80 years of age or older (48.1%; 95% CI, 44.6 to 51.6). Nearly two thirds of hospitalizations were due to unintentional overdoses (65.7%; 95% CI, 60.1 to 71.3). Four medications or medication classes were implicated alone or in combination in 67.0% (95% CI, 60.0 to 74.1) of hospitalizations: warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), and oral hypoglycemic agents (10.7%). High-risk medications were implicated in only 1.2% (95% CI, 0.7 to 1.7) of hospitalizations. CONCLUSIONS: Most emergency hospitalizations for recognized adverse drug events in older adults resulted from a few commonly used medications, and relatively few resulted from medications typically designated as high-risk or inappropriate. Improved management of antithrombotic and antidiabetic drugs has the potential to reduce hospitalizations for adverse drug events in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
National Hospital Discharge Survey, 1988: Archival Version
United States Department of Health and Human Services. National Center for Health Statistics (1991) · ICPSR Data Holdings · doi:10.3886/icpsr09521 · Cited by 1,310
Appropriate prescribing in elderly people: how well can it be measured and optimised?
Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61091-5 · Cited by 1,090
National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events
Budnitz, D. S., Pollock, D. A., Weidenbach, K. N., Mendelsohn, A. B., Schroeder, T. J., & Annest, J. L. (2006) · JAMA · doi:10.1001/jama.296.15.1858 · Cited by 893
Self-citationAging Biology and Geriatric Clinical Pharmacology
McLean, A. J., & Le Couteur, D. G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.4 · Cited by 771
Bormate, A. B., Leboit, P. E., & McCalmont, T. H. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.8.1020 · Cited by 731
Which drugs cause preventable admissions to hospital? A systematic review
Howard, R. L., Avery, A. J., Slavenburg, S., Royal, S., Pipe, G., Lucassen, P., & Pirmohamed, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02698.x · Cited by 625
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
Budnitz, D. S., Shehab, N., Kegler, S. R., & Richards, C. L. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00006 · Cited by 607
Self-citationHospital Admissions Resulting from Preventable Adverse Drug Reactions
McDonnell, P. J., & Jacobs, M. R. (2002) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2002)036<1331:harfpa>2.0.co;2 · Cited by 587
Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings
Grijalva, C. G. (2009) · JAMA · doi:10.1001/jama.2009.1163 · Cited by 513
Onder, G., Pedone, C., Landi, F., Cesari, M., Della Vedova, C., Bernabei, R., & Gambassi, G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50607.x · Cited by 501
Patient Safety At Ten: Unmistakable Progress, Troubling Gaps
Wachter, R. M. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0785 · Cited by 400
Inappropriate Medication Prescribing for Elderly Ambulatory Care Patients
Goulding, M. R. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.3.305 · Cited by 288
The Affordable Care Act and the Future of Clinical Medicine: The Opportunities and Challenges
Kocher, R., Emanuel, E. J., & DeParle, N.-A. M. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-8-201010190-00274 · Cited by 246
Pharmacokinetic-Pharmacodynamic Crisis in the Elderly
ELDesoky, E. S. (2007) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000183719.84390.4d · Cited by 219
Page, R. L., & Mark Ruscin, J. (2006) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2006.12.008 · Cited by 177
Beyond the Prescription: Medication Monitoring and Adverse Drug Events in Older Adults
Steinman, M. A., Handler, S. M., Gurwitz, J. H., Schiff, G. D., & Covinsky, K. E. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03500.x · Cited by 165
Geographic Variation in the Quality of Prescribing
Zhang, Y., D, K. B. A., & Newhouse, J. P. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1010220 · Cited by 117
Identifying hospital admissions due to adverse drug events using a computer‐based monitor
Jha, A. K., Kuperman, G. J., Rittenberg, E., Teich, J. M., & Bates, D. W. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.568 · Cited by 109
Shehab, N., Sperling, L. S., Kegler, S. R., & Budnitz, D. S. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.407 · Cited by 102
Self-citationJhung, M. A., Budnitz, D. S., Mendelsohn, A. B., Weidenbach, K. N., Nelson, T. D., & Pollock, D. A. (2007) · Medical Care · doi:10.1097/mlr.0b013e318041f737 · Cited by 88
Self-citationGage, B. F. (2009) · New England Journal of Medicine · doi:10.1056/nejme0906886 · Cited by 72
Kim, M. M., Metlay, J. P., Cohen, A. L., Feldman, H. I., Hennessy, S., Kimmel, S., Strom, B. L., & Doshi, J. A. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1953 · Cited by 41
Balancing Hypoglycemia and Glycemic Control: A Public Health Approach for Insulin Safety
POGACH, L. M., & Aron, D. C. (2010) · JAMA · doi:10.1001/jama.2010.655 · Cited by 41
National Trends In Use Of Medications In Office-Based Practice, 1985–1999
Burt, C. W. (2002) · Health Affairs · doi:10.1377/hlthaff.21.4.206 · Cited by 28
Spinler, S. A. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.7.812 · Cited by 16
Cited by
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Reducing Inappropriate Polypharmacy: The Process of Deprescribing
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., Gnjidic, D., Del Mar, C. B., Roughead, E. E., Page, A., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,584
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Schulman, S., Kakkar, A. K., Goldhaber, S. Z., Schellong, S., Eriksson, H., Mismetti, P., Christiansen, A. V., Friedman, J., Le Maulf, F., Peter, N., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004450 · Cited by 923
“the bleeding risk associated with vitamin K antagonists,(9) which is important because warfarin has been implicated in 33% of emergency hospitalizations for adverse drug events.(10) Dabigatran etexilate (hereafter referred to as dabigatran) is an orally administered direct thrombin inhibitor with an efficacy similar t…”
BackgroundSarode, R., Milling, T. J., Refaai, M. A., Mangione, A., Schneider, A., Durn, B. L., & Goldstein, J. N. (2013) · Circulation · doi:10.1161/circulationaha.113.002283 · Cited by 813
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Metadata
- Authors
- Budnitz, D. S., Lovegrove, M. C., Shehab, N., & Richards, C. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-11-24
- Volume
- 365
- Issue
- 21
- Pages
- 2002-2012
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2096721022
- Cited by
- 1,820
- References
- 28
- FWCI
- 62.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.